| Prospective Cohort Study of Association of Insulin Resistance/Steatosis With Hepatic Fibrosis in CHB and NAFLD (NCT02031913) | Seoul National University Boramae Hospital | 2013-01-01 |
| Sustained Viral Response in Patients Achieved HBsAg Level≤100 IU/ml After Completed Interferon Treatment (NCT02348502) | Beijing Ditan Hospital | 2013-01-01 |
| Sustained Viral Response in Chronic Hepatitis B Patients Who Achieved HBeAg Seroncongversion After Interferon Therapy (NCT02412592) | Beijing Ditan Hospital | 2013-01-01 |
| Efficacies of Entecavir Add on HBeAg Positive Patients With HBV DNA Positive During Peginterferon Alpha 2a Treatment (NCT02368288) | Beijing Ditan Hospital | 2013-01-01 |
| Efficacy of Peginterferon Alpha 2a Therapy in Chronic Hepatitis B Patients Being Treated With Nucleoside(Acid) Analogues (NCT02362490) | Beijing Ditan Hospital | 2013-01-01 |
| Study to Evaluate the Antiviral Efficacy, Safety and Tolerability of Tenofovir Disoproxil Fumarate Versus Placebo in Pediatric Participants With Chronic Hepatitis B Infection (NCT01651403) | Gilead Sciences | 2012-12-06 |
| Effectiveness of Nucleos(t)Ide Analogs (NUC) Therapy Among Naive CHB Patients in China (NCT01726439) | Bristol-Myers Squibb | 2012-12-01 |
| The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B (NCT02965859) | Guangzhou Yipinhong Pharmaceutical CO.,LTD | 2012-12-01 |
| Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B (NCT02881008) | Hepatera Ltd. | 2012-11-14 |
| TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA (NCT01732367) | Keimyung University Dongsan Medical Center | 2012-11-01 |
| Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma (NCT01872988) | Taichung Veterans General Hospital | 2012-09-01 |
| Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα (NCT01694264) | Seoul National University Hospital | 2012-09-01 |
| Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients (NCT01491295) | Taipei Veterans General Hospital, Taiwan | 2012-09-01 |
| Antiviral Efficacy of Switching to ETV Plus TDF (NCT01597934) | Yonsei University | 2012-08-01 |
| Entecavir Plus Tenofovir Combination in Subjects With Multi-drug Resistant Chronic Hepatitis B Virus Infection (NCT01594905) | Yonsei University | 2012-08-01 |
| Peg-interferon ADDed to an Ongoing Nucleos(t)Ide Based Treatment in Patients With Chronic Hepatitis B to Induce Decrease of HBs-Antigen (NCT01524679) | Johannes Gutenberg University Mainz | 2012-08-01 |
| Comparison Between Lamivudine and Entecavir Treatment in Spontaneous Severe Acute Exacerbation (NCT01627223) | Taichung Veterans General Hospital | 2012-07-01 |
| A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B (NCT03108794) | Beijing Friendship Hospital | 2012-06-30 |
| Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Treatment to Ncrease Sustained Response in CHB (NCT01532843) | Foundation for Liver Research | 2012-06-01 |
| PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients (NCT01373684) | Foundation for Liver Research | 2012-05-25 |
| Prospective Study In Noninvasive Evaluation of Hepatic Fibrosis in Chronic Hepatitis B (NCT01679769) | Peking University First Hospital | 2012-05-01 |
| Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir (NCT01588912) | Pusan National University Yangsan Hospital | 2012-04-01 |
| Efficay of Extended Peginterferon Alpha 2a Treatment in HBeAg Negative Chronic Hepatitis B Patients (NCT02387684) | Beijing Ditan Hospital | 2012-04-01 |
| Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB) (NCT01589952) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2012-03-01 |
| Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy (NCT01595633) | Yonsei University | 2012-03-01 |
| Efficacy of Extended Peginterferon Alpha 2a Treatment in HBeAg Positive Chronic Hepatitis B Patients (NCT02387463) | Beijing Ditan Hospital | 2012-03-01 |
| The Tolerability and Pharmacokinetics Clinical Trial of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers (NCT03180333) | Guangzhou Yipinhong Pharmaceutical CO.,LTD | 2012-03-01 |
| Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B (NCT02069678) | Chinese University of Hong Kong | 2012-03-01 |
| A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B (NCT01671787) | Gilead Sciences | 2012-03-01 |
| Prospective Observational Cohort Study for the Durability of Anti-viral Therapy in Patients With Chronic Hepatitis B (NCT01533051) | Yonsei University | 2012-02-01 |
| Life Course, HIV and Hepatitis B Among African Migrants Living in Ile-de-France (NCT02566148) | ANRS, Emerging Infectious Diseases | 2012-02-01 |
| Tenofovir in Chronic Hepatitis B With Mild ALT Elevation (NCT01522625) | E-DA Hospital | 2012-01-01 |
| A Study of Switch From Nucleotide to Peginterferon Alfa-2a in CHB Patients Achieving HBeAg Loss and HBV DNA <200IU/ml (NCT01464281) | The Second Affiliated Hospital of Chongqing Medical University | 2011-10-01 |
| Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients (NCT01436539) | Jun Cheng | 2011-09-01 |
| A Cohort Study in Korean Patients With Chronic Hepatitis B (CHB) Receiving Pegylated Interferon (NCT01531166) | Yonsei University | 2011-09-01 |
| Combination or Sequential Therapy of Peginterferon Alfa-2a and Entecavir for Patients With Chronic Hepatitis B (NCT01906580) | Beijing 302 Hospital | 2011-07-01 |
| NASVAC Phase-III Trial in Chronic Hepatitis B (CHB) Patients (NCT01374308) | Clinical Research Organization, Dhaka, Bangladesh | 2011-06-01 |
| Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B Patients (NCT01260610) | Institute of Liver and Biliary Sciences, India | 2011-06-01 |
| Lamivudine Extending Therapy in Chronic Hepatitis B Patients After 3-year of Oral Antiviral Agents (NCT02337127) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2011-06-01 |
| Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB) (NCT01380951) | The Fifth People's Hospital of Suzhou | 2011-05-01 |
| Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study (NCT01804387) | Korea University | 2011-05-01 |
| Stopping TDF Treatment After Long Term Virologic Suppression in HBeAg-negative CHB (NCT01320943) | Gilead Sciences | 2011-04-26 |
| Efficacy & Safety of Tenofovir Disoproxil Fumarate (TDF) Plus Peginterferon α-2a (Peg-IFN) Versus TDF or Peg-IFN Monotherapy in Chronic Hepatitis B (NCT01277601) | Gilead Sciences | 2011-04-01 |
| Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept (NCT01379508) | Novartis Pharmaceuticals | 2011-03-21 |
| Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis B (NCT01243281) | Chulalongkorn University | 2011-03-01 |
| A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis B (NCT01172392) | ANRS, Emerging Infectious Diseases | 2011-01-01 |
| Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation Therapy (NCT01270178) | Taipei Veterans General Hospital, Taiwan | 2011-01-01 |
| The Safety and Tolerability of Metacavir Enteric-coated Capsules in Healthy Adult Volunteers (NCT03173599) | Guangzhou Yipinhong Pharmaceutical CO.,LTD | 2010-12-01 |
| Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult Patients (NCT01267162) | Medical Procare PLLC | 2010-09-01 |
| Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography (NCT01360892) | Kindai University | 2010-09-01 |
| Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease (NCT01360879) | Kindai University | 2010-09-01 |
| Second Stage:Open-label Study of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B (NCT02862106) | Chongqing Jiachen Biotechnology Ltd. | 2010-09-01 |
| Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B (NCT01242787) | LG Life Sciences | 2010-08-01 |
| Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis B (NCT01143662) | Xiamen Amoytop Biotech Co., Ltd. | 2010-07-01 |
| Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis B (NCT01270165) | Yonsei University | 2010-06-01 |
| Therapeutic Hepatitis B Vaccine (Mimogen-based) Joint Entecavir in Treating Chronic Hepatitis B Patients (NCT01326546) | Chongqing Jiachen Biotechnology Ltd. | 2010-06-01 |
| Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B Patients (NCT01148576) | Zhejiang University | 2010-06-01 |
| Efficacy and Safety Study of Entecavir Plus Tenofovir in Patients With Chronic Hepatitis B Who Failed Previous Treatment (NCT01063036) | Bristol-Myers Squibb | 2010-05-01 |
| Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study (NCT01401400) | Foundation for Liver Research | 2010-05-01 |
| An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B (NCT01264354) | Bukwang Pharmaceutical | 2010-03-01 |
| A Control Study to Evaluate The Efficacy And Safety of Ozone-therapy in Chronic Hepatitis B (NCT01887275) | Nanfang Hospital, Southern Medical University | 2010-03-01 |
| Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis B (NCT01342185) | Nanfang Hospital, Southern Medical University | 2010-03-01 |
| Adefovir and Lamivudine for Entecavir Resistance (ALTER Study) (NCT01546116) | Korea University | 2010-02-01 |
| An Study of Efficacy and Safety of Clevudine (NCT01192854) | Eisai Co., Ltd. | 2010-02-01 |
| Efficacy Study of Telbivudine in Chronic Hepatitis B Patients (NCT01958229) | National Taiwan University Hospital | 2009-12-01 |
| Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected Patients (NCT01027065) | Cytheris SA | 2009-12-01 |
| A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long Period (NCT01264094) | Bukwang Pharmaceutical | 2009-11-01 |
| A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B (NCT01264133) | Bukwang Pharmaceutical | 2009-09-01 |
| Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis B (NCT01026610) | LG Life Sciences | 2009-08-01 |
| Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B (NCT00877760) | Foundation for Liver Research | 2009-08-01 |
| Health Promotion and Management for Hepatitis B Carriers (NCT01065363) | National Taiwan University Hospital | 2009-08-01 |
| A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV Patients (NCT01266005) | Bukwang Pharmaceutical | 2009-08-01 |
| Rollover Protocol Continued Access to Emtricitabine/Tenofovir Disoproxil Fumarate for Adults in United States (NCT00936715) | Gilead Sciences | 2009-08-01 |
| Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects (NCT00964665) | Novartis Pharmaceuticals | 2009-07-01 |
| An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received Clevudine (NCT01264107) | Bukwang Pharmaceutical | 2009-04-01 |
| Phase 2 Trial of Therapeutic Hepatitis B Vaccine (Mimogen-based) for Chronic Hepatitis B (NCT00869778) | Chongqing Jiachen Biotechnology Ltd. | 2009-04-01 |
| PEG-IFN in HBV Patients With Incomplete Response to NA (NCT00883844) | Foundation for Liver Research | 2009-04-01 |
| Prednisolone Priming Study in Patients With Chronic Hepatitis B (NCT00778596) | Yun-Fan Liaw | 2009-02-01 |
| Study of Telbivudine in Chronic Hepatitis B (NCT00970216) | Chang Gung Memorial Hospital | 2009-02-01 |
| Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis B (NCT00907894) | Novartis Pharmaceuticals | 2009-02-01 |
| Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B (NCT01743079) | Beijing YouAn Hospital | 2009-01-01 |
| Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients (NCT00798460) | Inje University | 2008-12-01 |
| Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB) (NCT00804622) | The University of Hong Kong | 2008-12-01 |
| Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis B (NCT01926288) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2008-10-01 |
| Sustained HBsAg and Viral Response in Patients Achieved HBsAg Loss by Interferon Treatment (NCT02336399) | Beijing Ditan Hospital | 2008-09-01 |
| Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels (NCT01337791) | Southeast University, China | 2008-08-01 |
| A Phase IIIb Study to Compare Entecavir Plus Tenofovir vs. Adefovir Added to Continuing Lamivudine Therapy in Adult Patients With Lamivudine-Resistant Hepatitis B Infection (NCT00605384) | Bristol-Myers Squibb | 2008-08-01 |
| A Study to Evaluate Tenofovir Disoproxil Fumarate (DF) in Asian-American Adults With Chronic Hepatitis B Infection (NCT00736190) | Gilead Sciences | 2008-08-01 |
| HBsAg Clearance in Inactive Chronic HBsAg Carriers After Interferon Treated (NCT01471535) | Beijing Ditan Hospital | 2008-05-01 |
| Tenofovir in Asian Chronic Hepatitis B Patients (NCT01728935) | The University of Hong Kong | 2008-04-01 |
| Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients (NCT00715715) | Maimonides Medical Center | 2008-04-01 |
| CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study (NCT00645736) | Gilead Sciences | 2008-02-01 |
| Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B (NCT00597259) | National Taiwan University Hospital | 2008-01-01 |
| Efficacy and Tolerance of Naked DNA Vaccine in Patients With Chronic B Hepatitis (NCT00536627) | French National Agency for Research on AIDS and Viral Hepatitis | 2008-01-01 |
| Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B Patients (NCT00558493) | Bukwang Pharmaceutical | 2007-11-01 |
| Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B (NCT00606099) | Novartis | 2007-11-01 |
| A Study to Compare Tenofovir DF Versus the Combination of Emtricitabine Plus Tenofovir DF for the Treatment of Chronic Hepatitis B in Patients With Normal Alanine Aminotransferase (ALT) (NCT00507507) | Gilead Sciences | 2007-09-01 |
| Truvada Versus Truvada Plus Hepatitis B Immunoglobulin (HBIg) in Prevention of Chronic Hepatitis B Recurrence Post Liver Transplant (NCT00507689) | Gilead Sciences | 2007-09-01 |
| Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine (NCT00513968) | Genexine, Inc. | 2007-07-01 |
| Long-term Study With Clevudine (NCT00558818) | Bukwang Pharmaceutical | 2007-06-01 |